Newsroom

LONDON--(BUSINESS WIRE)--  Xtrackers Investment company with variable capital (Société d'investissement à capital variable) Registered office: 49, avenue J.F. Kennedy, L-1855 Luxembourg R.C.S. Luxembourg B-119.899 (the “Company”) NOTICE TO SHAREHOLDERS OF THE SUB-FUNDS LISTED ON THE LONDON STOCK EXCHANGE Luxembourg, 09 December 2025 The board of directors of the Company (the “Board of Directors”) hereby informs all shareholders of the sub-funds listed in the table below (each a “Sub-Fund”, and...

BEIJING & SHANGHAI & HONGKONG--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. („Biocytogen”, SSE: 688796; HKEX: 02315), ein globales Biotechnologieunternehmen, das innovative Arzneimittelforschung vorantreibt, gab heute seine erfolgreiche Notierung an der Shanghai Stock Exchange STAR Market bekannt. Dies folgt auf die Notierung des Unternehmens an der Hong Kong Stock Exchange im September 2022 und markiert einen bedeutenden Meilenstein bei der Etablierung von Biocytogen als ers...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Alerian Disruptive Technology Real Estate UCITS ETF 09.12.2025 LANDXEN.LN IE000C75IMX8 22,412.00 USD 414,484.11 18.494  ...

PEKÍN, SHANGHÁI Y HONG KONG--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. («Biocytogen», SSE: 688796; HKEX: 02315), empresa biotecnológica global dedicada a la investigación para crear fármacos innovadores, acaba de anunciar su salida a bolsa en el mercado STAR de la Bolsa de Shanghái. Esto se produce tras empezar a cotizar en la Bolsa de Hong Kong en septiembre de 2022 y supone un importante hito para Biocytogen como la primera empresa farmacéutica innovadora global con dobl...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Alerian Disruptive Technology Real Estate UCITS ETF 09.12.2025 LANDXN.LN IE000RN036E0 28,035.00 USD 561,436.78 20.026  ...

LOS ANGELES--(BUSINESS WIRE)--Policy professor and water consultant Randall Crane was seated Tuesday as the Municipal Water District of Orange County’s newest representative on the board of directors of the Metropolitan Water District of Southern California. Crane is a professor emeritus at the UCLA Luskin School of Public Affairs, where he studied water governance, infrastructure planning, transportation, and the economic development challenges of cities. Through his career, he has advised the...

MEMPHIS, Tenn.--(BUSINESS WIRE)--Propeller, the digital platform that connects fans to causes through culture, community and experiences, today announced an opportunity to take action to be entered to win two tickets to Super Bowl LX with proceeds benefitting the lifesaving mission of St. Jude Children’s Research Hospital®: Finding cures. Saving children.® The opportunity is offered in partnership with the Legends for Charity® Dinner, which presents The Pat Summerall Award annually during Super...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Indxx Innovative Transaction & Process UCITS ETF 09.12.2025 LEGR LN IE00BF5DXP42 1,025,002.00 USD 48,864,788.57 47.673  ...

PÉKIN, SHANGHAI et HONG KONG--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (« Biocytogen », SSE : 688796 ; HKEX : 02315), une société internationale de biotechnologie spécialisée dans la découverte de médicaments innovants, a annoncé aujourd’hui son introduction réussie sur le marché STAR de la Bourse de Shanghai. Ce lancement fait suite à celui de la société à la Bourse de Hong Kong en septembre 2022 et marque une étape importante dans l’établissement de Biocytogen en tant q...

RADNOR, Pa.--(BUSINESS WIRE)--The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Klarna Group plc (NYSE: KLAR) (“Klarna”). Klarna provides payment, advertising, and digital retail banking solutions to consumers and merchants. On or around September 10, 2025, Klarna conducted its IPO at $40.00 per share. On November 18, 2025, Klarna issued its third quarter 2025 financial r...